首页>
外国专利>
OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-BETA
OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-BETA
展开▼
机译:局部应用雄激素或TGF-BETA治疗角膜结膜干燥症的眼部治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The topical application, at a dose rate less than or equal to 0.1 mg day, to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutically effective amount of an androgen or androgen analogue or a therapeutically effective amount of TGF- beta is disclosed as a method of relieving the chronic and acute manifestation of dry eye signs and symptoms in keratoconjunctivitis sicca (KCS), for example in Sj+E,uml o+EE gren's syndrome.
展开▼
机译:以小于或等于0.1毫克/天的剂量率向含有治疗有效量的雄激素或雄激素类似物或治疗有效量的TGF-β的制剂的眼表或眼睛的邻近区域局部施用公开了作为减轻干燥性角结膜炎(KCS),例如Sj + E,um + EE gren综合征的干眼症状和症状的慢性和急性表现的方法。
展开▼